DG
23
2
SE
52
2
JPM
62
2
ACN
38
2
MSI
60
2
DAL
80
3
INTC
36
8
AMZN
56
5
PFE
25
9
EQR
37
-5
CI
52
7
AIZ
47
-2
ADI
49
3
XYL
33
-4
CNP
36
-8
CSCO
56
3
HON
58
3
GLW
52
2
TEL
66
16
OKE
62
-8
DG
23
2
SE
52
2
JPM
62
2
ACN
38
2
MSI
60
2
DAL
80
3
INTC
36
8
AMZN
56
5
PFE
25
9
EQR
37
-5
CI
52
7
AIZ
47
-2
ADI
49
3
XYL
33
-4
CNP
36
-8
CSCO
56
3
HON
58
3
GLW
52
2
TEL
66
16
OKE
62
-8
Financhill
Back

Verve Therapeutics Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
1

VERV
Verve Therapeutics

Last Price:
6.04
Seasonality Move:
-35.34%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Verve Therapeutics Price Quote

$6.04
+0.11 (+1.86%)
(Updated: November 4, 2024 at 5:55 PM ET)

Verve Therapeutics Key Stats

Sell
1
Verve Therapeutics (VERV) is a Sell
Day range:
$5.65 - $5.96
52-week range:
$4.31 - $20.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.44
P/B ratio:
0.92%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-49.53%
Market cap:
$501.8M
Revenue:
$11.8M
EPS:
$-2.59

How Much Does Verve Therapeutics Make?

Is Verve Therapeutics Growing As A Company?

  • What Is Verve Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.2%
  • What Is Verve Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Verve Therapeutics Stock Price Performance

What Is Verve Therapeutics 52-Week High & Low?

Verve Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verve Therapeutics?

Is Verve Therapeutics Cash Flow Positive?

  • What Is VERV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$129.7M
  • What Is Verve Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $233.3M
  • What Is Verve Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$32.2M

Verve Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VERV return on invested capital is -36.29%
  • What Is Verve Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -28.44%
  • What Is VERV Return On Equity?
    ROE is a measure of profitability and is -36.29%

Verve Therapeutics Earnings Date & Stock Price

Verve Therapeutics Competitors

Verve Therapeutics Dividend Yield

Verve Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10.83%
Revenue: 219.73% 146.89%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 26.01
Upside from Last Price: 338.6%

Major Shareholders

  • How many VERV shares are owned by institutional investors?
    114.5M VERV shares are owned by institutional investors
  • How many VERV shares are owned by insiders?
    1.2M VERV shares are owned by insiders